Concepedia

Publication | Open Access

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

DOIFull Paper Access

155

Citations

19

References

2020

Year

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen M. Neuzil, Mark J. Mulligan, Ruth Bailey,

Unknown Venue

Abstract

These results support selection of the BNT162b2 vaccine candidate for Phase 2/3 large-scale safety and efficacy evaluation, currently underway.

References

YearCitations

Page 1